3Grow WB,Moreb JS,Roque D,et al.Late onset of invasive aspergillus infention in bone marrow transplant patients at a university hospotal[J].Bone Marrow Transplant,2002,29(2):15-19.
4Ascioglu S,Rex JH,de Pauw B,et al.Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus[J].Clin Infect Dis,2002,34(1):7-14.
5Martino R,Subir(a) M,Domingo-Albs+ A,et al.Low-dose amphotericin B lipid complex for the treatment fever of unknown origin in patients with hematologic malignancies and prolonged neutropenia[J].Chemotherapy,1999,45(3):205-212.
6Walsh TJ,Finberg RW,Arndt C,et al.Liposomal ampheotericin B for empirical therapy in patients with persistent fever and neutropenia[J].N Engl J Med,1999,340(10):764-771.
7Tedder M,Spratt JA,Anstadt MP,Hegde SS,Tedder SD,Lowe JE.Pulmonary mucormycosis:results of medical and surgical therapy.Ann Thorac Surg,1994,57:1044-1050.
8Lee FY,Mossad SB,Adal KA.Pulmonary mucormycosis:the last 30 years.Arch Intern Med,1999,159:1301-1309.
9Abraham P,Govil S,Srivastava VM,Ganesh A.Sponta-neous regression of pulmonary mucormycosis.Postgrad Med J,1995,71:632 -634.
10Pagano L,Ricci P,Tonso A,et al.Mucormycosis in patients with haematological malignancies:a retrospective clinical study of 37 cases.Br J Haematol 1997 ;99:331-336.
